Zev A Wainberg Clinical Oncology Society of Australia Annual Scientific Meeting 2023

Abstracts this author is presenting:

• NAPOLI-3: A randomized, open-label phase 3 study of NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naïve patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) — Best of the Best Oral Presentations - Clinical Research